| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection
|
De Fino, Chiara
|
|
2016
|
5 |
C |
p. 70-72
3 p.
|
artikel
|
| 2 |
A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of >10 years in multi-ethnic Penang, Malaysia: Clinical features and disease course
|
Hor, Jyh Yung
|
|
2016
|
5 |
C |
p. 89-90
2 p.
|
artikel
|
| 3 |
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes
|
Zhornitsky, Simon
|
|
2016
|
5 |
C |
p. 53-65
13 p.
|
artikel
|
| 4 |
Editors' Welcome
|
Banwell, Brenda
|
|
2016
|
5 |
C |
p. A1-
1 p.
|
artikel
|
| 5 |
Effects of a virtual reality and treadmill training on gait of subjects with multiple sclerosis: a pilot study
|
Peruzzi, Agnese
|
|
2016
|
5 |
C |
p. 91-96
6 p.
|
artikel
|
| 6 |
Erratum to; “Stopping immunomodulatory medications in MS: Frequency, reasons and consequences”
|
Tobin, W.O.
|
|
2016
|
5 |
C |
p. 105-
1 p.
|
artikel
|
| 7 |
Ganglion cell analysis in acute optic neuritis
|
Behbehani, R.
|
|
2016
|
5 |
C |
p. 66-69
4 p.
|
artikel
|
| 8 |
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients
|
Joseph, Dhanya
|
|
2016
|
5 |
C |
p. 7-11
5 p.
|
artikel
|
| 9 |
Important role of mast cells in multiple sclerosis
|
Conti, P.
|
|
2016
|
5 |
C |
p. 77-80
4 p.
|
artikel
|
| 10 |
In Memoriam: John F. Kurtzke, MD, FACP, FAAN 1926–2015
|
Wallin, Mitchell T.
|
|
2016
|
5 |
C |
p. A2-
1 p.
|
artikel
|
| 11 |
Longitudinal associations between brain structural changes and fatigue in early MS
|
Nourbakhsh, Bardia
|
|
2016
|
5 |
C |
p. 29-33
5 p.
|
artikel
|
| 12 |
Longitudinal associations between MRI and cognitive changes in very early MS
|
Nourbakhsh, Bardia
|
|
2016
|
5 |
C |
p. 47-52
6 p.
|
artikel
|
| 13 |
Multiple sclerosis relapse mimicking a transient ischemic attack
|
Perren, Fabienne
|
|
2016
|
5 |
C |
p. 27-28
2 p.
|
artikel
|
| 14 |
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
|
Comi, Giancarlo
|
|
2016
|
5 |
C |
p. 97-104
8 p.
|
artikel
|
| 15 |
Reducing clinical trial risk in multiple sclerosis
|
De Gasperis-Brigante, C.D.
|
|
2016
|
5 |
C |
p. 81-88
8 p.
|
artikel
|
| 16 |
Regulatory T cell number in multiple sclerosis patients: A meta-analysis
|
Noori-Zadeh, Ali
|
|
2016
|
5 |
C |
p. 73-76
4 p.
|
artikel
|
| 17 |
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life
|
Milinis, K.
|
|
2016
|
5 |
C |
p. 34-39
6 p.
|
artikel
|
| 18 |
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes
|
Scott, Thomas F.
|
|
2016
|
5 |
C |
p. 1-6
6 p.
|
artikel
|
| 19 |
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
|
Fiest, K.M.
|
|
2016
|
5 |
C |
p. 12-26
15 p.
|
artikel
|
| 20 |
The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis
|
Datt, Joe
|
|
2016
|
5 |
C |
p. 40-46
7 p.
|
artikel
|
Tijdschrift beschrijving